Current Trends in Implantable Left Ventricular Assist Devices

Table 1

Survival after HVAD Implantation: Evaluation of HeartWare HVAD left ventricular assist device for the treatment of advanced heart failure: Results of the ADVANCE Bridge to transplant Trial.

ADVANCE Trial Outcomes at 180 days*
Transplant or alive	92.0%
Alive	62.8%
Transplant	29.2%
Device exchange	4.4%
Death	3.6%

* Presentation at the AHA meeting 2010 [14].